Our platform technologies are versatile. We are capable of rapidly generating lead compounds for a variety of disease indications.

Peptides derived from our platforms are applicable in broad therapeutic areas such as neurodegeneration, oncology and cardiovascular diseases. Also, in orphan diseases.

Using our platform technologies, we welcome collaboration with pharma/biotech companies: 1) partner on one of our targets; 2) we can develop a peptide for one of your targets.